Based upon the outcomes of the research study, Sanofi and Regeneron will certainly start the procedure of obtaining Dupixent accepted in the United States later on this year.
发布者:BY MIKKEL AABENHUS HEMMINGSEN,转转请注明出处:https://robotalks.cn/phase-iii-results-send-multi-blockbuster-closer-to-another-indication/